Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241
PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed…
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
June 14, 2025 10:48 ET Â | Source: Celldex Therapeutics, Inc. 77% of…
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
June 13, 2025 16:52 ET Â | Source: Vaxart, Inc. SOUTH SAN FRANCISCO,…
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
June 13, 2025 16:22 ET Â | Source: 23andMe, Inc. TTAM Commits to…
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 13, 2025 16:01 ET Â | Source: Nurix Therapeutics, Inc. SAN FRANCISCO,…
JZXN Raises Funds through Convertible Notes to Acquire Bitcoin, Initiating a Strategic Layout of Thousands of Bitcoins
HANGZHOU, China, June 11, 2025 /PRNewswire/ --Â JZXN Holdings, Inc. (NASDAQ: JZXN; the…
ACM Research to Participate at the 15th Annual ROTH London Conference
June 13, 2025 16:05 ET Â | Source: ACM Research, Inc. FREMONT, Calif.,…
Monolithic Power Systems Announces Second Quarter 2025 Dividend
June 13, 2025 16:01 ET Â | Source: Monolithic Power Systems, Inc. KIRKLAND,…
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchits Concurrent Financing
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- 1317229 B.C. Ltd.…